Browse Category

Dividend Investing 10 December 2025 - 12 December 2025

ST Engineering (SGX:S63) Stock: Latest News, Dividend Outlook, and Analyst Forecasts as of Dec 12, 2025

ST Engineering (SGX:S63) Stock: Latest News, Dividend Outlook, and Analyst Forecasts as of Dec 12, 2025

ST Engineering shares rose 1.58% to S$8.34 as of 2:08pm in Singapore after the company announced a new defence partnership with France’s Safran and signaled a possible strategic move for its loss-making iDirect unit. The board is also considering a dividend plan that could raise FY2025 payouts above earlier expectations.
TELUS Stock Hits New 12‑Month Low After BMO Downgrade — What a 9% Dividend and Deleveraging Plan Mean for Investors

TELUS Stock Hits New 12‑Month Low After BMO Downgrade — What a 9% Dividend and Deleveraging Plan Mean for Investors

TELUS shares hit a new 12-month low near C$17.75 on December 11 after BMO Capital Markets downgraded the stock and cut its price target to C$19. The move followed TELUS’s decision to pause dividend growth and launch a deleveraging plan. The stock now yields about 9.4%, but analysts flagged concerns over valuation, payout ratios, and uncertainty around TELUS Digital.
Chevron (CVX) Stock After November 21, 2025: Latest News, Insider Moves, 2026 Outlook and Dividend Forecast

Chevron (CVX) Stock After November 21, 2025: Latest News, Insider Moves, 2026 Outlook and Dividend Forecast

Chevron shares traded near $151 on December 10, about 10% below their 52-week high. The company completed a $53 billion Hess acquisition, reported record Q3 production, and plans $10–$20 billion in annual buybacks through 2030. Chevron guides 2026 capex at $18–$19 billion and expects $12–12.5 billion in extra free cash flow by 2026. Analyst sentiment is mostly positive, but some warn of oil-price and integration risks.
11 December 2025
AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie shares rebounded 2.98% to $236.28 on Nov. 21, 2025, with trading volume spiking to 7.9 million after three down days. Year-to-date, the stock is up about 22–26%, outpacing the S&P 500, but remains 7–9% below its October high. Forward P/E estimates range from 16x to 22x. Investors weigh strong Skyrizi and Rinvoq sales against Humira declines and regulatory risk.
Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Coca-Cola shares traded around $69–70 intraday on December 11, 2025, down from late-November highs above $73 but well above the 52-week low. The board named Henrique Braun as CEO effective March 31, 2026, with James Quincey moving to Executive Chairman. KO delivered an estimated 11.9% one-year return, lagging the S&P 500 but outperforming its industry.
T-Mobile US (TMUS) Stock on December 11, 2025: Dividend Growth, Analyst Targets and 5G Scrutiny

T-Mobile US (TMUS) Stock on December 11, 2025: Dividend Growth, Analyst Targets and 5G Scrutiny

T-Mobile US shares traded near $196 on December 11, 2025, close to 12-month lows and down about 9% year-to-date. The company raised its quarterly dividend by 16% to $1.02 per share in September and faces increased regulatory and competitive pressure as it invests in 5G. T-Mobile’s Hometown Grants program has awarded $20 million to 450 U.S. communities.
Caterpillar (CAT) Stock at Record Highs: AI Infrastructure Tailwinds, Dividend Strength and 2026 Outlook

Caterpillar (CAT) Stock at Record Highs: AI Infrastructure Tailwinds, Dividend Strength and 2026 Outlook

Caterpillar shares traded near $615 midday December 11, close to record highs, after a 66% year-to-date gain that pushed its market value to almost $290 billion. Q3 revenue rose 9–10% to $17.6 billion, but operating margin fell to 17.3% as costs increased. The stock’s forward P/E is about 33, more than double its industry average. Energy and transportation now drive most earnings.
Best UK Stocks to Buy Now (11 December 2025): 9 FTSE Shares for 2026 Growth, Income and Value

Best UK Stocks to Buy Now (11 December 2025): 9 FTSE Shares for 2026 Growth, Income and Value

The FTSE 100 hovered near record highs around 9,600–9,700 on December 11, 2025, after a strong rally led by banks, energy, miners, and defense stocks. Despite a 22.8% total return for the year, UK equities remain valued below global peers at about 12.5 times 2026 earnings. Inflation has eased to the mid-3% range, and the Bank of England’s base rate sits near 4% after earlier cuts. Investors remain cautious as European shares dip and tech stocks weaken.
Verizon Communications Inc. (VZ) Stock on December 10, 2025: Price, Dividend Yield, Layoffs and Wall Street Forecasts

Verizon Communications Inc. (VZ) Stock on December 10, 2025: Price, Dividend Yield, Layoffs and Wall Street Forecasts

Verizon shares traded near $40 Wednesday after a 2.8% drop Tuesday on heavy volume. Morgan Stanley cut its price target to $47, citing a tougher telecom outlook. Institutional investors showed mixed moves, with Intact Investment Management trimming its stake and BCS Private Wealth opening a new position. Verizon’s dividend yield remains near 7%, among the highest in the Dow.
Medical Properties Trust (MPW) Stock in December 2025: Dividend Hike, Heavy Short Interest and a High‑Risk Turnaround

Medical Properties Trust (MPW) Stock in December 2025: Dividend Hike, Heavy Short Interest and a High‑Risk Turnaround

Medical Properties Trust shares trade at $5.54 with a market cap of $3.3 billion and a forward dividend yield above 6% after a 12% dividend hike announced November 17. The hospital REIT’s stock has rebounded about 40% year-to-date but remains among the most shorted in the U.S. MPW owns nearly 400 hospital properties across nine countries. Five-year total return is still down roughly 60% from pre-2022 levels.
10 December 2025
Merck (MRK) Stock on December 10, 2025: Price Action, Dividend Catalyst, Analyst Targets and the Keytruda Question

Merck (MRK) Stock on December 10, 2025: Price Action, Dividend Catalyst, Analyst Targets and the Keytruda Question

Merck shares traded near $97.31 Wednesday afternoon, up slightly after Tuesday’s 2% drop. Volume topped 3.2 million as investors tracked dividend moves and new analyst upgrades. The stock remains about 25% below 2024 highs despite a 41% six-month rally. Signs of rising competition to Keytruda and looming patent pressures weighed on sentiment.
Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Campbell’s (CPB) Stock Hits 52‑Week Lows After Q1 2026 Earnings and Fitch Downgrade – Is the 5.5% Dividend Worth the Risk?

Campbell’s shares hit a new 52-week low of $28.13 on December 10, dropping further after a post-earnings slide. Fitch downgraded the company’s credit rating to BBB- with a Stable outlook, citing high leverage and weak trends. Q1 fiscal 2026 results showed sales down 3% and adjusted EPS down 13%, but both slightly beat analyst estimates. Margins fell as tariffs and inflation drove costs higher.
Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

The FTSE 100 rose yesterday as gains in BAE Systems and Rolls-Royce offset losses in British American Tobacco. Investors are positioning for possible rate cuts in 2026, with UK inflation down to 3.6% in October. The Bank of England expects the upcoming budget to further reduce inflation and says banks remain resilient. FTSE 100 companies are set to repurchase about £56.6bn in stock this year.
Singtel (SGX: Z74) Stock on 10 December 2025: Price, Dividend Payout, Buyback Firepower and 2026 Outlook

Singtel (SGX: Z74) Stock on 10 December 2025: Price, Dividend Payout, Buyback Firepower and 2026 Outlook

Singtel shares traded near record highs at S$4.58 on December 10, after a year-long rally of about 50–55%. The company posted a 14% rise in underlying net profit to S$1.35 billion for H1 FY26 and raised full-year guidance. Its Australian unit Optus faces fallout from network failures and a record court fine. Singtel’s dividend yield is close to 4%.
Macquarie Group (ASX: MQG) Stock Outlook on 10 December 2025: Qube Bid, Dividend Payout and 2026 Forecasts

Macquarie Group (ASX: MQG) Stock Outlook on 10 December 2025: Qube Bid, Dividend Payout and 2026 Forecasts

Macquarie Group shares traded at A$194.7 in Sydney on 10 December 2025, flat over the past week and down nearly 12% year-to-date. The company reported a first-half net profit of A$1.655 billion, up 3% year-on-year but below market expectations. A major A$11.6 billion takeover proposal remains under review. An increased interim dividend is due next week.
1 2 3 4 5 6 9
Go toTop